ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 8 Issue 3, Fall 1994

September 12, 1994

Sense Of Excitement, Challenges, Mark Healy’s Debut

April 26, 1991

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

April 4, 1980

In Brief: Deadline June 1 For Cancer Research Institute Grants; Chabner To Present Karnofsky Lecture

May 3, 1985

Scientists Falsified Research, ORI Says

July 5, 1996

Improved Prediction Of Cancer To Increase Pressure On Prevention, Greenwald Says

August 15, 1986